Merrimack Pharmaceuticals Inc (MACK) Return on Investment ROI from the first quarter of 2024 to first quarter of 2023 and for the year 2024, average high and low, overall ranking from Mar 31 2024 to Mar 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Merrimack Pharmaceuticals Inc  (NASDAQ: MACK)


Merrimack Pharmaceuticals Inc's ROI from its first quarter of 2024 to the first quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Merrimack Pharmaceuticals Inc's ROI in the first quarter of 2024?
Merrimack Pharmaceuticals Inc achieved a return on average invested assets (ROI) of 288.18 % in its first quarter of 2024, this is above MACK's average return on investment of -104.63%.
Merrimack Pharmaceuticals Inc invested over the 12 months ending in its first quarter of 2024 $70 million

ROI has improved compared to -6.24% in the fourth quarter of 2023, due to net income growth.

Within the Healthcare sector Merrimack Pharmaceuticals Inc achieved the highest return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2023 from 0 to 19.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Investment Change TTM 326.6 % 26.01 % 38.49 % 25.05 % 12.51 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 222 19 19 19 19
Return On Investment (TTM) 288.18 % -6.24 % -7.52 % -9.04 % -10.32 %
MACK's Overall Ranking # 19 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 267.26 % -0.66 % 7.95 % 8.31 % 8.48 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 200 -1 -1 -2 -2

MACK Company Profile >> Back to MACK Roi Comparisons >> See Annual MACK Return On Investment



Return On Investment MACK's Ranking
Within: No.
Industry # 0
Sector # 1
Overall # 19

Return On Investment Statistics
High Average Low
1439.61 %
-104.63 %
-3317.05 %
(Jun 30 2017)   (Mar 31 2017)







Financial Statements
Merrimack Pharmaceuticals Inc's I. Quarter Investments $ 222 Millions MACK's Balance sheet
Merrimack Pharmaceuticals Inc's I. Quarter Income $ 201 Millions Quarterly MACK's Income Statement
MACK's Income by Division See MACK's Income by Division


MACK Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions 19 19 14 16 17
Y / Y Investment Growth -2.6 % 35.67 % -11.36 % -7.54 % -76.53 %
Net Income in Millions -1 -2 0 -3 -17
Y / Y Net Income Growth - - - - -
Annual Return On Investment -6.3 % -8.02 % 0 % -18.92 % -100.12 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MACK's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MACK's Competitors
Subscribers only: Roi for Merrimack Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for MACK's Customers

Other Ratios
MACK's Roa MACK's Inventory Turnover Ratio MACK's Growth Rates MACK's Dividend Statistics
MACK's Profitability Ratios MACK's Asset Turnover Ratio MACK's Dividend Growth
MACK's Roe MACK's Valuation Ratios MACK's Financial Strength Ratios MACK's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2024, within Healthcare Sector ROI
Ir med Inc   388.57 %
Merrimack Pharmaceuticals Inc  288.18 %
WEED, INC.  249.65 %
Ladrx Corporation  207.75 %
Glucotrack Inc   197.58 %
Entera Bio Ltd   99.87 %
Biomx Inc  90.73 %
Roivant Sciences Ltd   86.83 %
Scynexis Inc   85.60 %
Scienture Holdings Inc   60.88 %
Enzo Biochem Inc  58.18 %

Date modified: 2026-09-12T06:14:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.